Medibyt
AI Platform for Cardiopulmonary Exercise Test Interpretation
Company Overview
Snapshot
Founded in May 2024 by Or Inbar and Niv Caspi, Medibyt operates with 1–10 employees. The company has raised $350,000 across two funding rounds, focusing on advancing its AI platform for cardiopulmonary exercise test interpretation.
Business overview
Medibyt develops an AI-powered platform designed to automate the interpretation of cardiopulmonary exercise tests (CPET) and streamline clinical workflows. Its core product, CPETWise, converts complex physiological data into structured, clinician-ready reports, significantly reducing analysis time. The cloud-based solution is compatible with existing metabolic systems, enabling remote diagnostics and seamless integration into hospital and outpatient settings. Medibyt serves the healthcare industry, specifically targeting providers within the Health Tech & Life Sciences sector, with a focus on medical decision support.
Strategic signal
Medibyt's technology, particularly its CPETWise platform, is positioned to address a significant need in cardiopulmonary assessment. Recent academic publications, including one in the European Journal of Applied Physiology in March 2025, highlight the paradigm shift towards comprehensive medical evaluation of exercise function using CPET. This external validation from leading research suggests a growing market acceptance and clinical relevance for AI-driven solutions like Medibyt's, signaling strong potential for adoption and impact in diagnostic accuracy and testing throughput.
Log in to access full profile ›Company Intelligence Q&A
- What is Medibyt's primary product?
- Medibyt's primary product is CPETWise, an AI-powered platform that automates the interpretation of cardiopulmonary exercise tests (CPET) and generates structured, clinician-ready reports.
- When was Medibyt founded and by whom?
- Medibyt was founded in May 2024 by Or Inbar and Niv Caspi.
- What is the total capital raised by Medibyt?
- Medibyt has raised a total of $350,000 across two funding rounds.
- What is the core technology behind Medibyt's platform?
- Medibyt's platform leverages artificial intelligence, specifically machine learning, to interpret cardiopulmonary exercise test data.
- What market does Medibyt primarily serve?
- Medibyt primarily serves the healthcare market, focusing on providers within the Health Tech & Life Sciences sector, with its solutions for medical decision support.